Pharmacogenetics of Membrane Transporters: An Update on Current Approaches

被引:96
|
作者
Sissung, Tristan M. [2 ]
Baum, Caitlin E. [1 ]
Kirkland, C. Tyler [1 ]
Gao, Rui [1 ]
Gardner, Erin R. [3 ]
Figg, William D. [1 ,2 ]
机构
[1] NCI, Mol Pharmacol Sect, Med Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA
[2] NCI, Clin Pharmacol Program, Med Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA
[3] NCI, Clin Pharmacol Program, SAIC Frederick, Frederick, MD 21702 USA
基金
美国国家卫生研究院;
关键词
ABCB1; ABCC1; ABCC2; ABCG2; OATP1B3; OATP1B1; Pharmacogenetics; Membrane transporters; SINGLE NUCLEOTIDE POLYMORPHISMS; CANCER RESISTANCE PROTEIN; HUMAN MDR1 GENE; OATP1B1; OATP-C; P-GLYCOPROTEIN; ORGANIC ANION; IN-VITRO; ORAL BIOAVAILABILITY; FUNCTIONAL-CHARACTERIZATION; MULTIDRUG TRANSPORTERS;
D O I
10.1007/s12033-009-9220-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This review provides an overview of the pharmacogenetics of membrane transporters including selected ABC transporters (ABCB1, ABCC1, ABCC2, and ABCG2) and OATPs (OATP1B1 and OATP1B3). Membrane transporters are heavily involved in drug clearance and alters drug disposition by actively transporting substrate drugs between organs and tissues. As such, polymorphisms in the genes encoding these proteins may have significant effects on the absorption, distribution, metabolism and excretion of compounds, and may alter pharmacodynamics of many agents. This review discusses the techniques used to identify substrates and inhibitors of these proteins and subsequently to assess the effect of genetic mutation on transport, both in vitro and in vivo. A comprehensive list of substrates for the major drug transporters is included. Finally, studies linking transporter genotype with clinical outcomes are discussed.
引用
收藏
页码:152 / 167
页数:16
相关论文
共 50 条
  • [21] Advances in Glioblastoma Therapy: An Update on Current Approaches
    Angom, Ramcharan Singh
    Nakka, Naga Malleswara Rao
    Bhattacharya, Santanu
    BRAIN SCIENCES, 2023, 13 (11)
  • [22] Population approaches in pharmacogenetics
    Goldstein, DB
    JOURNAL OF MEDICAL GENETICS, 2004, 41 : S27 - S27
  • [23] An update on the pharmacogenetics of treating hypertension
    V Fontana
    M R Luizon
    V C Sandrim
    Journal of Human Hypertension, 2015, 29 : 283 - 291
  • [24] Update on pharmacogenetics in cancer chemotherapy
    Innocenti, F
    Ratain, MJ
    EUROPEAN JOURNAL OF CANCER, 2002, 38 (05) : 639 - 644
  • [25] An update on the pharmacogenetics of treating hypertension
    Fontana, V.
    Luizon, M. R.
    Sandrim, V. C.
    JOURNAL OF HUMAN HYPERTENSION, 2015, 29 (05) : 283 - 291
  • [26] Pharmacogenetics and stomach cancer: an update
    Toffoli, Giuseppe
    Cecchin, Erika
    PHARMACOGENOMICS, 2007, 8 (05) : 497 - 505
  • [27] Pharmacogenetics of drug transporters and its impact on the pharmacotherapy
    Sakaeda, T
    Nakamura, T
    Okumura, K
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2004, 4 (13) : 1385 - 1398
  • [28] Computational Approaches for Revealing the Structure of Membrane Transporters: Case Study on Bilitranslocase
    Venko, Katja
    Choudhury, A. Roy
    Novic, Marjana
    COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2017, 15 : 232 - 242
  • [29] Eradicating biofilm infections: an update on current and prospective approaches
    da Silva, Ronni A. G.
    Afonina, Irina
    Kline, Kimberly A.
    CURRENT OPINION IN MICROBIOLOGY, 2021, 63 : 117 - 125
  • [30] Current Pharmacologic Approaches in Painful Bladder Research: An Update
    Andersson, Karl-Erik
    Birder, Lori
    INTERNATIONAL NEUROUROLOGY JOURNAL, 2017, 21 (04) : 235 - 242